AK-47 indoor Organic CBD Flowers
AK-47 CBD flower heads
Purchase natural CBD flowers
AK-47 Certificate CBD Flowers

AK-47 (Organic Indoor) - CBD 9,8%

Grown organically in hydroponics in Italy and hand-harvested, this AK-47 with 9.8% CBD reveals flavours of citrus, pine and spicy notes. Firm, compact buds and an especially fine trim: a highly aromatic sativa-dominant hybrid.
Regular price 17,80 € Sale price instead of 20,00 €

Availability: In stock – Ships within 24h

8,90 €/g
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

Organic Indoor CBD Flower AK-47 9.8%

  • Organic hydroponic cultivation in Italy (Indoor)
  • Citrus and pine flavours with spicy notes
  • CBD 9.8%
  • Sativa-dominant hybrid
  • Hand-harvested

See all products:

Details

Organic Indoor CBD Flower AK-47

Superb aroma, firm and compact buds, a particularly careful trim and a very fine harvest this year on this Sativa-dominant hybrid.

Cultivation method
Organic hydroponic cultivation carried out indoors (Indoor) in Italy, then hand-harvested.

Species
Sativa-dominant hybrid

Concentration

  • CBD: 9.8%
  • THC: 0.19%

Certification
CBD flower grown in the EU, then certified by a GMP-approved laboratory. You will find the certificate of analysis for this product among the photos on this page.

Legislation
100% legal product throughout the EU. This variety is a hybrid derived from varieties authorised in the European catalogue.

*Photos are non-contractual, taken by us and from the batch currently on sale*

Aromas

AK-47 CBD Flowers, natural, organic hydroponic cultivation

  • Pine
  • Spicy
  • Citrus

Similar products

Discover other Indoor CBD flowers:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. MILDECA (2021). L'indispensable sur... le cannabidiol (CBD). MILDECA — drogues.gouv.fr. View the source
  2. MILDECA (2023). Le CBD. drogues.gouv.fr (Mission interministérielle de lutte contre les drogues et les conduites addictives). View the source
  3. Chevallier C, Charuel L, Richeval C, Chaouachi L, Del Valle L, Eiden C, Gaulier JM, Batisse A (CEIP-A Paris, Lyon, Montpellier ; CHU Lille) (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source
  4. Dryburgh LM, Bolan NS, Grof CPL, et al. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. View the source

Recently viewed